Prof. Galileo Escobedo studied Experimental Biology in the Health Science Division of the Metropolitan University of Mexico. After this, he started his Ph.D. education in the Biomedical Research Ph.D. program, at the Department of Immunology of the Biomedical Research Institute of the National Autonomous University of Mexico. In 2006, he moved to Dr. Craig Robert's lab at the University of Strathclyde, Glasgow, Scotland. He received his Ph.D. (2008) working on the molecular and cellular mechanisms involved in the relationship between the immune response and the neuro-endocrine system during health and disease. Immediately after, he moved to Dr. Ignacio Camacho's lab at the School of Chemistry of the National University of Mexico, where he studied the role of hormones in improving the inflammatory immune response against intestinal pathogens. At the end of 2009, he incorporated at the Unit of Experimental Medicine, School of Medicine, National University of Mexico, General Hospital of Mexico, National Institutes of Health, where he works on the topics concerning the role of the inflammatory response in developing obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). Dr. Escobedo's current research topics focus on the role of proinflammatory cytokines and chemokines in mediating the recruitment of classically-activated macrophages into the adipose tissue and liver of morbidly obese patients, as well as type 2 diabetic patients.
